Market News
Stay updated with the latest market trends, earnings, and economic indicators.
Stock Market Crash: Biggest single-day Nifty fall in 21 months wipes out ₹13 lakh crore market cap
10 stocks on the Nifty 50 are now trading at 52-week lows, led by Bajaj Finance, HDFC Bank, Bajaj Finserv, HUL and Cipla.
Stock market crash: HDFC Bank, ITC, Patanjali Foods, Cipla among 311 stocks that hit 52-week low on NSE - Upstox
Stock market crash: HDFC Bank, ITC, Patanjali Foods, Cipla among 311 stocks that hit 52-week low on NSEUpstox
Cipla, GSPL among 6 stocks that hit 52-week lows; slip up to 24% in a month
Seven stocks from the BSE 500 index slipped to their 52-week lows. A 52-week low marks the lowest level a stock has traded at over the past year, and is closely tracked by traders and investors to gauge valuations and potential future price trends.
Cipla Share Price Live Updates: Cipla's beta indicates a steady stock
Cipla Share Price Live Updates: Cipla Stock Price History
Jefferies adds Wipro, Hyundai Motor India, Cipla to latest underperform list. Here’s why
Jefferies has added Wipro, Hyundai Motor India and Cipla to its latest underperform list, citing weak growth outlook, rising competition and earnings risks. The brokerage flagged slow deal ramp ups at Wipro, market share losses for Hyundai and US revenue pressure at Cipla as key concerns for investors.
Cipla Share Price Live Updates: Cipla's Daily Performance
Cipla's US subsidiary initiates recall of Lanreotide injection, leading to temporary shortage
Cipla USA Inc. recalls Lanreotide injection batches, causing a temporary shortage. The recall follows US FDA's OAI classification of Pharmathen's facility in Greece. Production may resume by Q4.
Stocks in news: Kwality Walls, AU Small Finance Bank, YES Bank, PB Fintech, Tata Power
Indian markets faced pressure on Friday, losing some recent gains due to cautious global sentiment and profit-taking. Several companies like PB Fintech, Kwality Walls, Cipla, AU Small Finance Bank, YES Bank, and Tata Power are in focus. Block deals occurred in PB Fintech. Kwality Walls reported Q3FY26 revenue. Cipla is recalling medication in the US.
Cipla USA recalls Nilotinib anti-cancer capsules over manufacturing issue: USFDA
Cipla USA is recalling over 400 cartons of its generic anti-cancer drug Nilotinib Capsules (150 mg and 200 mg) due to a manufacturing issue, the US Food and Drug Administration has said. The recall affects specific batches distributed in the United States.
Cipla recalls over 400 cartons of cancer drug in US: FDA
Cipla USA is recalling over 400 cartons of its anti-cancer drug Nilotinib Capsules. The recall is due to a manufacturing issue where the capsules failed to meet specifications. This is a voluntary Class III recall, meaning it is not expected to cause adverse health consequences.
Stocks to Watch for March 4: ONGC, HPCL, Petronet, IGL, Cipla, Tata Motors CV, M&M and more
From all the Middle East-linked names, which continue to remain in the spotlight due to the Iran war, to stocks like Tata Motors CV, M&M, Affle 3I, these names should be on your radar going into Wednesday's trading session.